Eastern Bank Acquires New Position in Waters Co. (NYSE:WAT)

Eastern Bank bought a new position in shares of Waters Co. (NYSE:WATFree Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 300 shares of the medical instruments supplier’s stock, valued at approximately $111,000.

A number of other large investors have also modified their holdings of the business. State Street Corp boosted its holdings in Waters by 1.9% during the third quarter. State Street Corp now owns 2,577,733 shares of the medical instruments supplier’s stock worth $927,700,000 after buying an additional 49,194 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Waters by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,416,683 shares of the medical instruments supplier’s stock worth $508,123,000 after acquiring an additional 16,703 shares in the last quarter. Janus Henderson Group PLC boosted its stake in shares of Waters by 0.7% during the 3rd quarter. Janus Henderson Group PLC now owns 885,593 shares of the medical instruments supplier’s stock worth $318,717,000 after acquiring an additional 6,256 shares in the last quarter. Van ECK Associates Corp grew its holdings in shares of Waters by 1.0% in the 3rd quarter. Van ECK Associates Corp now owns 659,539 shares of the medical instruments supplier’s stock worth $219,811,000 after acquiring an additional 6,647 shares during the period. Finally, Principal Financial Group Inc. increased its stake in Waters by 70.7% in the 3rd quarter. Principal Financial Group Inc. now owns 656,019 shares of the medical instruments supplier’s stock valued at $236,095,000 after purchasing an additional 271,804 shares in the last quarter. 94.01% of the stock is owned by hedge funds and other institutional investors.

Waters Trading Up 1.2 %

WAT opened at $404.70 on Wednesday. The firm has a market capitalization of $24.03 billion, a P/E ratio of 38.62, a P/E/G ratio of 6.92 and a beta of 1.01. The firm’s 50 day moving average is $377.07 and its 200-day moving average is $347.34. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14. Waters Co. has a 52-week low of $279.24 and a 52-week high of $406.78.

Waters (NYSE:WATGet Free Report) last issued its quarterly earnings data on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, topping analysts’ consensus estimates of $2.68 by $0.25. The firm had revenue of $740.30 million for the quarter, compared to analyst estimates of $712.99 million. Waters had a net margin of 21.43% and a return on equity of 49.93%. The firm’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.84 EPS. Analysts expect that Waters Co. will post 11.79 EPS for the current fiscal year.

Analyst Ratings Changes

WAT has been the subject of several recent research reports. Wells Fargo & Company raised their target price on shares of Waters from $380.00 to $415.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Scotiabank started coverage on shares of Waters in a research report on Monday, December 23rd. They set a “sector perform” rating and a $430.00 price target for the company. JPMorgan Chase & Co. lifted their price target on shares of Waters from $340.00 to $380.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft upped their price objective on Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Finally, Stifel Nicolaus lifted their target price on Waters from $332.00 to $360.00 and gave the company a “hold” rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $384.71.

Read Our Latest Stock Analysis on WAT

Waters Company Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.